2022•Value in HealthOpen access

EE224 Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring (RTCGM) vs Self-Monitoring of Blood Glucose (SMBG) in Patients With Type 1 Diabetes in the Netherlands

J Isitt, Greg Cogswell, Hamza Alshannaq, Peter Lynch, GJ Norman, S Roze

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Glycemic, Medicine, Hypoglycemia, Continuous glucose monitoring, Type 2 diabetes, Blood Glucose Self-Monitoring, Type 1 diabetes, Randomized controlled trial

Back to paper search Browse research topics Original source

EE224 Cost-Effectiveness Analysis of Real-Time Continuous Glucose Monitoring (RTCGM) vs Self-Monitoring of Blood Glucose (SMBG) in Patients With Type 1 Diabetes in the Netherlands — Research Paper | ScholarLens